Silencing of LncRNA C1RL-AS1 Suppresses the Malignant Phenotype in Gastric Cancer Cells via the AKT/β-Catenin/c-Myc Pathway
Purpose: Numerous studies have shown that lncRNAs play vital roles in the development and progression of cancer. However, investigations of lncRNAs in gastric cancer are limited and need to be further pursued.Materials and Methods: According to RNA-seq results of gastric cancer (GC) tissues, we iden...
Main Authors: | Wu Zhen-Hua, Gong Yi-Wei, Zhao Li-Qin, Zhang Jie-Yun, Gong Zhe, Guo Wei-Jian |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.01508/full |
Similar Items
-
Immunological and clinicopathological characteristics of C1RL in 2120 glioma patients
by: Junyou Wang, et al.
Published: (2020-09-01) -
PDGFA‐associated protein 1 is a novel target of c‐Myc and contributes to colorectal cancer initiation and progression
by: Hong‐Yong Cui, et al.
Published: (2022-08-01) -
The SIRT1-c-Myc axis in regulation of stem cells
by: Wei Fan, et al.
Published: (2023-07-01) -
Transcription factor FoxM1 is the downstream target of c-Myc and contributes to the development of prostate cancer
by: Huafeng Pan, et al.
Published: (2018-03-01) -
F-ATP synthase inhibitory factor 1 regulates metabolic reprogramming involving its interaction with c-Myc and PGC1α
by: Lishu Guo, et al.
Published: (2023-07-01)